
PMID- 29258264
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180108
IS  - 1424-8247 (Print)
IS  - 1424-8247 (Linking)
VI  - 10
IP  - 4
DP  - 2017 Dec 18
TI  - Convenient Preparation of (18)F-Labeled Peptide Probes for Potential Claudin-4
      PET Imaging.
LID - E99 [pii]
LID - 10.3390/ph10040099 [doi]
AB  - Since pancreatic cancer is often diagnosed in a late state of cancer development,
      diagnostic opportunities allowing early disease detection are highly sought
      after. As such, cancer expression of claudin proteins is markedly dysregulated,
      making it an attractive target for molecular imaging like positron emission
      tomography (PET). Claudins are a family of transmembrane proteins that have a
      pivotal role as members of the tight junctions. In particular, claudin-3 and
      claudin-4 are frequently overexpressed in pancreatic cancer. (18)F-Labeled
      claudin selective peptides would provide access to a novel kind of imaging tools 
      for pancreatic cancer. In this work we describe the synthesis of the first
      (18)F-labeled probes potentially suitable for PET imaging of claudin-4
      expression. These probes were prepared using oxime ligation of
      5-[(18)F]fluoro-5-deoxyribose (5-[(18)F]FDR) to claudin selective peptides. As a 
      proof-of-principle, one of them, 5-[(18)F]FDR-Clone 27, was isolated in >98%
      radiochemical purity and in 15% radiochemical yield (EOB) within 98 min, and with
      a molar activity of 4.0 GBq/mumol (for 30 MBq of tracer). Moreover, we present
      first biological data for the prepared 5-FDR-conjugates. These tracers could pave
      the way for an early diagnosis of pancreatic tumor, and thus improve the outcome 
      of anticancer therapy.
FAU - Feni, Lucia
AU  - Feni L
AD  - Department of Chemistry, Biochemistry, Zulpicher Str. 47a, 50674 Cologne,
      Germany. lfeni@uni-koeln.de.
FAU - Omrane, M Aymen
AU  - Omrane MA
AD  - Institute of Neuroscience and Medicine, INM-5: Nuclear Chemistry,
      Forschungszentrum Julich GmbH, Wilhelm-Johnen Str., 52425 Julich, Germany.
      a.omrane@fz-juelich.de.
AD  - Institute of Radiochemistry and Experimental Molecular Imaging, University Clinic
      Cologne, Kerpener Str. 62, 50937 Cologne, Germany. a.omrane@fz-juelich.de.
FAU - Fischer, Moritz
AU  - Fischer M
AD  - Department of Chemistry, Biochemistry, Zulpicher Str. 47a, 50674 Cologne,
      Germany. mfisch11@smail.uni-koeln.de.
FAU - Zlatopolskiy, Boris D
AU  - Zlatopolskiy BD
AUID- ORCID: 0000-0001-5818-1260
AD  - Institute of Neuroscience and Medicine, INM-5: Nuclear Chemistry,
      Forschungszentrum Julich GmbH, Wilhelm-Johnen Str., 52425 Julich, Germany.
      boris.zlatopolskiy@uk-koeln.de.
AD  - Institute of Radiochemistry and Experimental Molecular Imaging, University Clinic
      Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
      boris.zlatopolskiy@uk-koeln.de.
AD  - Max Planck Institute for Metabolism Research, Gleueler Str. 50, 50931 Cologne,
      Germany. boris.zlatopolskiy@uk-koeln.de.
FAU - Neumaier, Bernd
AU  - Neumaier B
AUID- ORCID: 0000-0001-5425-3116
AD  - Institute of Neuroscience and Medicine, INM-5: Nuclear Chemistry,
      Forschungszentrum Julich GmbH, Wilhelm-Johnen Str., 52425 Julich, Germany.
      b.neumaier@fz-juelich.de.
AD  - Institute of Radiochemistry and Experimental Molecular Imaging, University Clinic
      Cologne, Kerpener Str. 62, 50937 Cologne, Germany. b.neumaier@fz-juelich.de.
AD  - Max Planck Institute for Metabolism Research, Gleueler Str. 50, 50931 Cologne,
      Germany. b.neumaier@fz-juelich.de.
FAU - Neundorf, Ines
AU  - Neundorf I
AD  - Department of Chemistry, Biochemistry, Zulpicher Str. 47a, 50674 Cologne,
      Germany. ines.neundorf@uni-koeln.de.
LA  - eng
PT  - Journal Article
DEP - 20171218
PL  - Switzerland
TA  - Pharmaceuticals (Basel)
JT  - Pharmaceuticals (Basel, Switzerland)
JID - 101238453
PMC - PMC5748654
OTO - NOTNLM
OT  - 18F-labeling
OT  - 5-[18F]FDR
OT  - PET-imaging
OT  - claudin receptors
OT  - pancreatic cancer
OT  - targeting peptides
COIS- The authors declare no conflict of interest.
EDAT- 2017/12/21 06:00
MHDA- 2017/12/21 06:01
CRDT- 2017/12/21 06:00
PHST- 2017/11/08 00:00 [received]
PHST- 2017/12/08 00:00 [revised]
PHST- 2017/12/13 00:00 [accepted]
PHST- 2017/12/21 06:00 [entrez]
PHST- 2017/12/21 06:00 [pubmed]
PHST- 2017/12/21 06:01 [medline]
AID - ph10040099 [pii]
AID - 10.3390/ph10040099 [doi]
PST - epublish
SO  - Pharmaceuticals (Basel). 2017 Dec 18;10(4). pii: ph10040099. doi:
      10.3390/ph10040099.
